Detalles de la búsqueda
1.
Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res
; 28(11): 2313-2320, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35254415
2.
Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors.
Clin Cancer Res
; 27(13): 3620-3629, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33883177
3.
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer.
Clin Cancer Res
; 27(23): 6413-6423, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34433653
4.
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma.
Ther Adv Med Oncol
; 11: 1758835919889001, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31853265
5.
Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT Elevation.
Toxicol Sci
; 163(1): 265-278, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29432567
6.
Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.
Cancer Res
; 63(17): 5224-9, 2003 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14500349
7.
Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy.
Mol Cancer Ther
; 4(5): 715-25, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15897235
8.
An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients.
Oncogene
; 23(55): 8859-67, 2004 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-15480432
9.
The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.
Clin Cancer Res
; 9(9): 3476-85, 2003 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12960140
10.
Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma.
Eur J Cancer
; 50(3): 496-505, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24262587
11.
Phase I pharmacokinetic and pharmacodynamic dose-escalation study of RG7160 (GA201), the first glycoengineered monoclonal antibody against the epidermal growth factor receptor, in patients with advanced solid tumors.
J Clin Oncol
; 29(28): 3783-90, 2011 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21900113
Resultados
1 -
11
de 11
1
Próxima >
>>